Trials / Enrolling By Invitation
Enrolling By InvitationNCT01370512
Droxidopa / Pyridostigmine in Orthostatic Hypotension
Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine Hypertension
- Status
- Enrolling By Invitation
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to study the combination of pyridostigmine and low-dose Droxidopa for the treatment of orthostatic hypotension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Droxidopa | 100 mg tablets by mouth three times a day |
| DRUG | Pyridostigmine | 60 mg tablets by mouth three times a day |
| OTHER | Placebo | Looks exactly like the study drug but contains no active ingredients |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2011-06-10
- Last updated
- 2025-07-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01370512. Inclusion in this directory is not an endorsement.